Strata Critical Medical, Inc.SRTA
Mentioned
Impact on stocks 1
Industrials
Strata Critical Medical, Inc.Strata Critical Medical, Inc.Blade Air Mobility reported mixed second-quarter results, with revenue of $72.51 million, a 60.7% year-over-year increase that beat estimates by $4.9 million, while GAAP earnings per share of negative $0.12 missed by $0.10. Adjusted EBITDA reached $7.9 million, representing a 10.9% margin, and cash flow from operating activities was $5.7 million, with free cash flow of $2.9 million. The company updated its 2026 guidance, raising revenue expectations to a range of $285 million to $295 million from the prior $260 million to $275 million, and increasing Adjusted EBITDA guidance to $33 million to $35 million from $29 million to $33 million. Free cash flow before aircraft and engine acquisitions guidance was maintained at $15 million to $22 million. On a pro forma basis assuming all 2026 acquisitions closed on January 1, 2026, revenue would be approximately $295 million to $305 million and Adjusted EBITDA would be $36 million to $38 million.
Strata Critical Medical, Inc.